pI: 4.6104 |
Length (AA): 449 |
MW (Da): 52812 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 14 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
279 | 363 | 2ckl (A) | 8 | 92 | 19.00 | 0 | 0.78 | 0.38 | -0.49 |
290 | 331 | 1chc () | 8 | 50 | 40.00 | 0.000015 | 1 | 0.58 | -0.26 |
4 | 115 | 2oto (A) | 69 | 184 | 6.00 | 0.22 | 0 | 0.249443 | -0.18 |
8 | 133 | 4r61 (A) | 10 | 149 | 9.00 | 0.13 | 0 | 0.444624 | -1.22 |
261 | 369 | 4ayc (B) | 374 | 483 | 17.00 | 0.022 | 0.25 | 0.545062 | -1.4 |
263 | 332 | 3zni (A) | 345 | 416 | 26.00 | 0.52 | 1 | 0.506202 | -0.33 |
287 | 328 | 1rmd (A) | 23 | 65 | 40.00 | 0.066 | 0.99 | 0.534141 | 0.28 |
289 | 338 | 4tkp (B) | 14 | 70 | 43.00 | 0.95 | 0.71 | 0.353659 | 0.36 |
10 | 129 | 2oto (A) | 65 | 184 | 12.00 | 0.21 | 0 | 0.349156 | 0 |
12 | 171 | 4u5a (C) | 48 | 238 | 21.00 | 0.0058 | 0.01 | 0.549242 | -0.83 |
259 | 367 | 4ayc (A) | 374 | 483 | 21.00 | 0.0099 | 0.26 | 0.567148 | -1.2 |
285 | 326 | 1rmd (A) | 23 | 65 | 40.00 | 0.065 | 0.99 | 0.53466 | 0.28 |
287 | 336 | 4tkp (B) | 14 | 70 | 43.00 | 0.51 | 0.71 | 0.354157 | 0.36 |
288 | 336 | 2ecw (A) | 22 | 76 | 35.00 | 0.11 | 1 | 0.46432 | -0.35 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, Oocyst, Ring, Sporozoite, Male Gametocyte. | Otto TD Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Female Gametocyte. | Lasonder E |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_128528)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G23780 | RING/U-box superfamily protein |
Arabidopsis thaliana | AT2G42030 | putative zinc ion binding protein |
Arabidopsis thaliana | AT2G44410 | RING/U-box domain-containing protein |
Arabidopsis thaliana | AT1G19310 | RING/U-box superfamily protein |
Babesia bovis | BBOV_III009770 | hypothetical protein |
Brugia malayi | Bm1_56615 | Hypothetical RING finger protein C16C10.7 in chromosome III |
Caenorhabditis elegans | CELE_C16C10.7 | Protein RNF-5 |
Cryptosporidium parvum | cgd2_1820 | hypothetical protein |
Dictyostelium discoideum | DDB_G0285333 | hypothetical protein |
Drosophila melanogaster | Dmel_CG32581 | CG32581 gene product from transcript CG32581-RB |
Drosophila melanogaster | Dmel_CG8974 | CG8974 gene product from transcript CG8974-RD |
Echinococcus granulosus | EgrG_001014900 | RING finger protein 185 |
Entamoeba histolytica | EHI_038330 | zinc finger domain containing protein |
Echinococcus multilocularis | EmuJ_001014900 | RING finger protein 185 |
Homo sapiens | ENSG00000138942 | ring finger protein 185 |
Homo sapiens | ENSG00000204308 | ring finger protein 5, E3 ubiquitin protein ligase |
Loa Loa (eye worm) | LOAG_06910 | hypothetical protein |
Mus musculus | ENSMUSG00000020448 | ring finger protein 185 |
Mus musculus | ENSMUSG00000015478 | ring finger protein 5 |
Neospora caninum | NCLIV_020050 | Zinc finger (C3HC4 RING finger) protein, related |
Oryza sativa | 4325492 | Os01g0766200 |
Oryza sativa | 4344731 | Os08g0162400 |
Oryza sativa | 4333714 | Os03g0678400 |
Oryza sativa | 4352888 | Os12g0636000 |
Plasmodium berghei | PBANKA_1126000 | E3 ubiquitin-protein ligase RNF5, putative |
Plasmodium falciparum | PF3D7_0627300 | E3 ubiquitin-protein ligase RNF5, putative |
Plasmodium knowlesi | PKNH_1122500 | E3 ubiquitin-protein ligase RNF5, putative |
Plasmodium vivax | PVX_114470 | E3 ubiquitin-protein ligase RNF5, putative |
Plasmodium yoelii | PY04641 | similar to CG8974 gene product-related |
Schistosoma japonicum | Sjp_0305250 | ko:K10666 E3 ubiquitin-protein ligase RNF5, putative |
Schistosoma mansoni | Smp_026260 | rnf5 |
Schmidtea mediterranea | mk4.009801.00 | Putative rnf5 |
Schmidtea mediterranea | mk4.005312.01 | |
Trypanosoma brucei gambiense | Tbg972.10.7780 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.6380 | ring finger containing protein |
Toxoplasma gondii | TGME49_205600 | zinc finger, C3HC4 type (RING finger) domain-containing protein |
Theileria parva | TP04_0895 | hypothetical protein |
Trichomonas vaginalis | TVAG_482150 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.6380 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.6380 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.6380 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.6380 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_205600 | Toxoplasma gondii | Essentiality uncertain | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.